Table 2

Baseline characteristics of each study and overall

Barbé et al10Robinson et al13Barbé et al9Craig et al12Total
Sample size54337243911202
Age (years)52.9 (9.8)54.3 (8.9)51.4 (10.9)57.7 (7.4)53.6 (10.2)
Gender (male)49 (91%)29 (88%)620 (86%)305 (78%)1003 (83%)
ESS7.4 (2.1)5.9 (2.6)6.5 (2.3)8.0 (4.3)7.0 (3.1)
ODI27.5 (18–37.6)9.8 (4.9–16.2)10.6 (5.4–19.1)
AHI53.6 (40.5–70)37 (27–55)38 (28–56)
SBP (mm Hg)134.7 (17.1)146.3 (18.5)131.2 (16.7)129.7 (12.7)131.2 (15.8)
DBP (mm Hg)83.8 (10.3)91.4 (12.1)80.0 (11.2)81.3 (7.9)80.9 (10.4)
BMI (kg/m2)29.4 (3.6)33.2 (5.3)31.3 (5.1)32.4 (5.6)31.6 (5.3)
Smokers17 (31%)208 (29%)45 (12%)270 (23%)
Cholesterol5.5 (1.1)5.2 (1.2)5.4 (1.1)
Antihypertensive medication21 (39%)27 (82%)260 (36%)193 (49%)501 (42%)
Prior vascular events2 (4%)222 (57%)224 (19%)
Diabetes4 (12%)63 (16%)67 (16%)
  • Data are summarised as mean (SD), median (25th—75th centile) or N(%) as appropriate. Note: not all baseline characteristics were available for all studies.

  • AHI, apnoea–hypopnoea index; BMI, body mass index; DBP, diastolic blood pressure; ESS, Epworth Sleepiness Score; ODI, oxygen desaturation index; SBP, systolic blood pressure.